In vivo protection by broadly neutralizing HIV antibodies
- PMID: 25169020
- DOI: 10.1016/j.tim.2014.08.006
In vivo protection by broadly neutralizing HIV antibodies
Abstract
Passive immunization studies, including a recent one by Pegu et al., have repeatedly shown that HIV-specific broadly neutralizing antibodies (bnAbs) protect rhesus macaques from HIV acquisition. In vitro neutralization potency and in vivo protection correlate very strongly, supporting the quest for an HIV vaccine that induces potent bnAbs.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical